Related Experiment Video

Updated: Jun 3, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors

Giovanni Marzaro1, Adriana Chilin, Adriano Guiotto

  • 1Department of Pharmaceutical Sciences, University of Padova, via marzolo 5, 35131 Padua, Italy. giovanni.marzaro@unipd.it

European Journal of Medicinal Chemistry
|March 31, 2011
PubMed

Insights

This study introduces novel multi-target quantitative structure-activity relationship (mtc-QSAR) models for designing tyrosine kinase inhibitors. These computational tools predict drug activity and selectivity, aiding cancer therapy development.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • Tyrosine kinases are crucial drug targets, often deregulated in cancers.
  • Developing novel tyrosine kinase inhibitors is vital for cancer treatment.
  • Existing computational tools for multi-target inhibitor design are limited.

Purpose of the Study:

  • To develop novel multi-target classification quantitative structure-activity relationship (mtc-QSAR) models.
  • To aid in the rational design of tyrosine kinase inhibitors with specific activity profiles.
  • To provide tools for predicting compound selectivity against multiple kinase targets.

Main Methods:

  • Development of several multi-target classification QSAR (mtc-QSAR) models.
  • Utilizing QSAR approaches for predicting compound activity and selectivity.
  • Focusing on tyrosine kinases as drug targets.

Main Results:

  • Successful development of mtc-QSAR models for tyrosine kinase inhibitors.
  • Demonstrated ability of models to predict activity and selectivity across multiple targets.
  • Provided a computational framework for assessing inhibitor profiles.

Conclusions:

  • The developed mtc-QSAR models are valuable for designing effective tyrosine kinase inhibitors.
  • These models can predict multi-target inhibitory profiles, crucial for anticancer drug discovery.
  • The study addresses the need for advanced cheminformatic tools in kinase inhibitor design.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...